Stryker (NYSE: SYK) holder plans sale of RSU shares from 2026 vesting

Rhea-AI Filing Summary

STRYKER CORP (SYK) received a notice of proposed sale of restricted securities under Rule 144 for the account of Debra King. The filing covers 826 common shares, acquired through RSU vesting on 08/01/2026, with an aggregate market value of 277,786. Stryker common stock outstanding is reported as 383,573,046 shares, and the proposed sale is approximately dated 08/18/2026 on the NYSE, with UBS Financial Services Inc. acting as broker and attorney-in-fact signing on King’s behalf.

Key Figures

Shares to be sold: 826 shares Aggregate market value: 277,786 Shares outstanding: 383,573,046 shares +2 more

5 metrics

Shares to be sold 826 shares Number of Stryker common shares covered by the Rule 144 notice

Aggregate market value 277,786 Aggregate market value of the securities to be sold

Shares outstanding 383,573,046 shares Stryker common shares outstanding referenced in the Form 144

Approximate sale date 08/18/2026 Approximate date of proposed Rule 144 sale on the NYSE

RSU vesting date 08/01/2026 Date the 826 shares were acquired via RSU vesting

Key Terms

Rule 144, RSU Vesting, aggregate market value, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

RSU Vesting financial

"Common | 08/01/2026 | RSU Vesting | Stryker Corp"

RSU vesting is the process by which restricted stock units — a promise by a company to give shares to an employee — become actual, owned shares over time or when certain goals are met. Investors care because vested shares can dilute existing ownership when issued, and the timing of vesting affects when employees can sell shares, which can influence share supply, insider selling patterns, and company incentives.

aggregate market value financial

"826 | 277786 | 383573046 | 08/18/2026 | NYSE"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

attorney-in-fact regulatory

"/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing for STRYKER CORP (SYK) disclose?

The Form 144 discloses a proposed Rule 144 sale for Debra King covering 826 shares of Stryker common stock. UBS Financial Services Inc. is listed as broker, with an approximate NYSE sale date of 08/18/2026.

How many SYK shares are proposed to be sold under this Form 144?

The notice covers a proposed sale of 826 shares of Stryker common stock. These shares were acquired via RSU vesting on 08/01/2026, and the filing reports an aggregate market value of 277,786 for the securities to be sold.

When were the SYK shares in this Form 144 acquired and how?

The shares in this Form 144 were acquired on 08/01/2026 through RSU vesting. The transaction description lists Stryker Corp as the source, with 826 shares acquired and payment characterized as a Wire on the same date.

What is the reported aggregate market value of Stryker (SYK) shares in this Form 144?

The filing reports an aggregate market value of 277,786 for the 826 common shares proposed for sale. This value appears in the securities information section, alongside the NYSE as the intended exchange for the sale.

How many SYK shares are outstanding according to this Form 144 notice?

The Form 144 states that 383,573,046 shares of Stryker common stock are outstanding. This figure is provided in the securities information section and serves as context for the 826 shares that may be sold under Rule 144.

Who is the broker for the proposed SYK share sale in this Form 144?

The broker listed is UBS Financial Services Inc., located at 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ 07086. UBS is identified in the securities information section and its representative signed as attorney-in-fact for Debra King.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 12:44 PM Accepted by SEC EDGAR 08/18/2026 - 12:44 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002055817
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Stryker Corp
SEC File Number	001-13149
Address of Issuer	1941 Stryker Way Portage MICHIGAN 49002
Phone	2693852600
Name of Person for Whose Account the Securities are To Be Sold	Debra King
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	826	277786	383573046	08/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/01/2026	RSU Vesting	Stryker Corp			826	08/01/2026	Wire

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Debra King
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)